NASDAQ:MGNX

MacroGenics Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$15.55

+0.770 (+5.21%)

At Close: May 01, 2024

Currently predicting for Thu, 2 May 2024

Trading levels for MGNX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	17.07	9.77 %
		R2	16.49	6.02 %
		R1	16.12	3.69 %
Current price:			15.55
	Support	S1	14.96	-3.82 %
		S2	14.59	-6.14 %
		S3	14.01	-9.90 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	17.78	14.34 %
		R2	17.43	12.09 %
		R1	15.93	2.44 %
Current price			15.55
	Support	S1	15.45	-0.675%
		S2	15.39	-1.03%
		S3	13.67	-12.09%

MGNX Predictions History

6 years ago
Jacob predicted that MGNX for 2018-04-30 is going $24.00 (2.39%)

Rank:

About MacroGenics

MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The... MGNX Profile

Golden Star

Ticker	Date	Change	Price
ETSY	Apr 26	1.84%	$67.43
DHT	Apr 24	1.24%	$11.28
LPLA	Apr 19	2.49%	$262.59
MLI	Apr 19	6.77%	$52.28
PFLT	Apr 18	1.07%	$11.25
DOOR	Apr 18	0.88%	$131.39
LNG	Apr 17	0.644%	$156.81
FCN	Apr 16	2.99%	$207.62
ELV	Apr 16	4.26%	$506.97
ITCI	Apr 05	4.92%	$68.44

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In